Endologix Reports Temporary Hold On AFX To Resolve Manufacturing Issue

(RTTNews) - Endologix Inc. (ELGX) announced a temporary hold on shipments of its AFX Endovascular AAA System to complete an investigation of a manufacturing issue with some sizes of the device.

The company said it expects the temporary hold to be lifted for some sizes in the near future.

"The temporary hold on AFX is not related to any reported events from physicians and we continue to see very good commercial clinical results with the latest versions of AFX and AFX2. The manufacturing issue was identified through our on-going product testing and we are proactively implementing the hold to ensure we always provide the safest possible products for patients," said John McDermott, Chief Executive Officer of Endologix.